Xtant Medical Holdings Inc XTNT
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if XTNT is a good fit for your portfolio.
News
-
Xtant Medical to Present at the Canaccord Genuity 44th Annual Growth Conference & Private Company Showcase
-
Xtant Medical to Participate in 21st Annual Craig-Hallum Institutional Investor Conference on May 29
-
Xtant Medical Reports First Quarter 2024 Revenue Growth of 55% and Raises Full Year 2024 Revenue Guidance
-
Xtant Medical to Issue First Quarter 2024 Financial Results on May 15, 2024
-
Xtant Medical Announces Launch of SimpliGraft™ and SimpliMax™ for Chronic and Acute Wounds
Trading Information
- Previous Close Price
- $0.73
- Day Range
- $0.73–0.80
- 52-Week Range
- $0.60–1.45
- Bid/Ask
- $0.72 / $0.92
- Market Cap
- $96.27 Mil
- Volume/Avg
- 6,828 / 75,755
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 0.96
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the US.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Value
- Total Number of Employees
- 215
- Website
- http://www.xtantmedical.com
Comparables
Valuation
|
Metric
|
XTNT
|
SIBN
|
7XC
|
|---|---|---|---|
Price/Earnings (Normalized) | — | — | — |
Price/Book Value | 2.02 | 4.01 | — |
Price/Sales | 0.96 | 4.48 | — |
Price/Cash Flow | — | — | — |
Price/Earnings
XTNT
SIBN
7XC
Financial Strength
|
Metric
|
XTNT
|
SIBN
|
7XC
|
|---|---|---|---|
Quick Ratio | 0.92 | 8.63 | 3.78 |
Current Ratio | 2.34 | 9.76 | 4.66 |
Interest Coverage | −0.05 | −13.62 | −28.71 |
Quick Ratio
XTNT
SIBN
7XC
Profitability
|
Metric
|
XTNT
|
SIBN
|
7XC
|
|---|---|---|---|
Return on Assets (Normalized) | −10.63% | −7.83% | −0.01% |
Return on Equity (Normalized) | −19.90% | −10.72% | −0.02% |
Return on Invested Capital (Normalized) | −9.14% | −10.92% | −0.22% |
Return on Assets
XTNT
SIBN
7XC
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| Prpzfqbf | Kkmflvk | $183.1 Bil | |||
| Stryker Corp
SYK
| Djvsmtpzf | Zbqmt | $126.3 Bil | |||
| Boston Scientific Corp
BSX
| Pkwhdjfq | Skxmll | $110.1 Bil | |||
| Medtronic PLC
MDT
| Tlywctwn | Nszwtbx | $100.9 Bil | |||
| Edwards Lifesciences Corp
EW
| Qthfwjvgdk | Dqybq | $37.6 Bil | |||
| DexCom Inc
DXCM
| Wvnlkynw | Tklq | $25.6 Bil | |||
| Koninklijke Philips NV ADR
PHG
| Lnpkpvdl | Ztsbs | $24.1 Bil | |||
| Steris PLC
STE
| Dddsjvxc | Kbxjsmn | $23.0 Bil | |||
| Zimmer Biomet Holdings Inc
ZBH
| Nsqfdyyg | Wtbd | $22.9 Bil | |||
| Align Technology Inc
ALGN
| Ngdqqtz | Bpttn | $16.6 Bil |